Movement Disorders From the Use of Metoclopramide and Other Antiemetics in the Treatment of Migraine

被引:24
作者
Wijemanne, Subhashie [1 ,2 ]
Jankovic, Joseph [1 ,2 ,3 ]
Evans, Randolph W. [3 ]
机构
[1] Baylor Coll Med, Parkinsons Dis Ctr, Houston, TX 77030 USA
[2] Baylor Coll Med, Movement Disorders Clin, Houston, TX 77030 USA
[3] Baylor Coll Med, Dept Neurol, 7200 Cambridge St,Suite 9A, Houston, TX 77030 USA
来源
HEADACHE | 2016年 / 56卷 / 01期
关键词
migraine; acute dystonic reaction; tardive dyskinesia; akathisia; metoclopramide; prochlorperazine; promethazine; TARDIVE-DYSKINESIA; ANTICHOLINERGIC PROPHYLAXIS; RANDOMIZED-TRIAL; ED TREATMENT; PROCHLORPERAZINE; AKATHISIA; INFUSION; DIPHENHYDRAMINE; HEADACHE; EFFICACY;
D O I
10.1111/head.12712
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Nausea and vomiting are a frequent accompaniment of migraine and anti-nausea medications are frequently used in its management. The majority of anti-nausea medications that are used in migraine are dopamine receptor blocking agents and therefore have the potential to cause drug-induced movement disorders. This article explores the risk of such drug-induced movement disorders in migraineurs who were treated with these medications.
引用
收藏
页码:153 / 161
页数:9
相关论文
共 68 条
[31]   Metoclopramide, an increasingly recognized cause of tardive dyskinesia [J].
Kenney, Christopher ;
Hunter, Christine ;
Davidson, Anthony ;
Jankovic, Joseph .
JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 48 (03) :379-384
[32]   Akathisia and anesthesia: Refusal of surgery after the administration of metoclopramide [J].
LaGorio, J ;
Thompson, VA ;
Sternberg, D ;
Dorje, P .
ANESTHESIA AND ANALGESIA, 1998, 87 (01) :224-227
[33]   DOMPERIDONE PLUS PARACETAMOL IN THE TREATMENT OF MIGRAINE [J].
MACGREGOR, EA ;
WILKINSON, M ;
BANCROFT, K .
CEPHALALGIA, 1993, 13 (02) :124-127
[34]   Upregulation of Dopamine D3, Not D2, Receptors Correlates With Tardive Dyskinesia in a Primate Model [J].
Mahmoudi, Souha ;
Levesque, Daniel ;
Blanchet, Pierre J. .
MOVEMENT DISORDERS, 2014, 29 (09) :1125-1133
[35]   Tardive dyskinesia and withdrawal emergent syndrome in children [J].
Mejia, Nicte I. ;
Jankovic, Joseph .
EXPERT REVIEW OF NEUROTHERAPEUTICS, 2010, 10 (06) :893-901
[36]   PERSISTENT AND PROGRESSIVE PARKINSONISM AFTER DISCONTINUATION OF CHRONIC NEUROLEPTIC THERAPY - AN ADDITIONAL TARDIVE SYNDROME [J].
MELAMED, E ;
ACHIRON, A ;
SHAPIRA, A ;
DAVIDOVICZ, S .
CLINICAL NEUROPHARMACOLOGY, 1991, 14 (03) :273-278
[37]   Prochlorperazine-Induced Tardive Dystonia and Its Worsening with Clozapine in a Non-Mentally III Patient with Migraine [J].
Mendhekar, Dattatreya N. ;
Andrade, Chittaranjan .
ANNALS OF PHARMACOTHERAPY, 2011, 45 (04) :545-546
[38]   METOCLOPRAMIDE-INDUCED MOVEMENT-DISORDERS - CLINICAL FINDINGS WITH A REVIEW OF THE LITERATURE [J].
MILLER, LG ;
JANKOVIC, J .
ARCHIVES OF INTERNAL MEDICINE, 1989, 149 (11) :2486-2492
[39]   Randomized evaluation of octreotide vs prochlorperazine for ED treatment of migraine headache [J].
Miller, Michael A. ;
Levsky, Marc E. ;
Enslow, William ;
Rosin, Alex .
AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2009, 27 (02) :160-164
[40]  
Modi S, 2015, NEUROCRIT CARE